BioHarvest Sciences
BHST | NASDAQ
$1.38
-$0.13 (-8.31%)
At close: Nov 16, 2026, 4:00 PM ET
$1.38
$0.00 (0.00%)
After-hours:
Nov 16, 2026, 7:30 PM ET
-8.31%
(1D)No price chart data available for 1D timeframe.
Rating
53.5
Fundamentals Strong
Market Sentiment Neutral
Moat Narrow
Sector Rank #331/882 (Top 38%)
Key Statistics
Market Data
Market Cap $31.28M
1D Range
1.38 1.47
52W Range
1.38 6.83
Valuation (TTM)
PE -2.51
PB 1.86
EV/EBITDA -3.95
Valuation (NTM)
Forward PE 34.20
Forward PEG 0.31
Price Target $5.00
Cash Flow
FCF Yield -36.2%
SBC Adj. FCF Yield -36.7%
SBC Impact -1.3%
Margins
Gross Margin 57.1%
Operating Margin -24.8%
FCF Margin -33.0%
Growth (CAGR)
Revenue 3Y | 5Y 47.9% |
83.8%
Dil EPS 3Y | 5Y 41.0% |
6.3%
FCF 3Y | 5Y -6.8% |
-2.7%
Returns
ROA -29.0%
ROE -55.9%
ROIC -24.2%
Financial Health
Net Cash
$5.84M
Current Ratio 2.13
Interest Coverage -2.09
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
BioHarvest Sciences Inc. is a biotechnology company that operates through two segments: Products and CDMO Services. The company has developed a botanical synthesis platform technology to grow plant ce...
Sector Industrials
Industry Agricultural - Commodities/Milling
Employees 89
IPO Date Jan 8, 2021
Website www.bioharvest.com
Fiscal Year January - December
Latest News
No news articles available yet.
Earnings
Latest Earnings
Nov 12, 2026
EPS
-$0.15
Beat +6.25%
YoY:
-7.14% REV
$7.87M
Miss -15.47%
YoY:
-13.23%Next Earnings
Mar 30, 2027
EPS Est
Pro
Rev Est
Pro
Analyst Summary
# of Analysts
2
Consensus
Buy
Price Target
$5.00
Upside
+262.32%
Buy (2)
Hold (0)
Sell (0)
Add to Watchlist
Select watchlists to add or remove BHST